atrial fibrillation, women, seniors, guidelines, blood thinners, DCRI

Nearly all women and people over 65 in the United States with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research Institute (DCRI).

The U.S. Food and Drug Administration (FDA) approved the ResQCPR System, a system of two devices for first responders to use while performing cardiopulmonary resuscitation (CPR) on cardiac arrest patients. The devices may improve the patientā€™s chances of surviving cardiac arrest.

March 9, 2015 ā€” Boston Scientific Corp. announced the settlement of the breach of merger agreement lawsuit brought by Johnson & Johnson against Guidant Corporation, stemming from Boston Scientific's acquisition of Guidant. In the lawsuit filed in 2006, Johnson & Johnson alleged that Guidant breached the merger agreement it had with Johnson & Johnson, and sought more thanĀ $7 billionĀ in damages. Guidant disputed the allegations.

Biotronik announced the presentation of data from the iliac arm of the BIOFLEX-I clinical trial at theĀ Cardiovascular Research Technologies (CRT)Ā conference in Washington, D.C. The BIOFLEX-I trial is designed to support U.S. Food and Drug Administration (FDA) approval of the Astron self-expanding nitinol stent to treat patients suffering from common iliac or external iliac artery disease.

AliveCor Inc.Ā announced the launch of the latest version of the AliveECG app, which instantly detects when an electrocardiogram (ECG) is either normal or unreadable.

Subscribe to
Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now